Welch T J, Stanson A W, Sheedy P F, Johnson C M, Miller W E, Johnson C D
Department of Diagnostic Radiology, Mayo Clinic, Rochester, MN 55905.
Mayo Clin Proc. 1988 Apr;63(4):343-7. doi: 10.1016/s0025-6196(12)64855-1.
During the period from August 1986 to August 1987, 50 patients underwent percutaneous placement of a Greenfield vena caval filter from the right femoral vein, left femoral vein, or right internal jugular vein at our institution. All 50 patients had a contraindication to anticoagulation therapy or had complications of anticoagulation for deep venous thrombosis or pulmonary emboli. The percutaneous placement was accomplished in the angiographic suite with use of local anesthesia and was well tolerated by all patients. Only three complications related to the percutaneous approach occurred during the short-term follow-up (3 months to 1 year). These complications were deep venous thrombosis of the leg in two patients and misplacement of the filter in one patient. The three patients tolerated these complications well. We conclude that placement of Greenfield vena caval filters can be readily accomplished by means of percutaneous entry. Our experience demonstrated minimal associated morbidity and no mortality.
1986年8月至1987年8月期间，我院有50例患者经皮从右股静脉、左股静脉或右颈内静脉置入格林菲尔德腔静脉滤器。所有50例患者均有抗凝治疗的禁忌证，或因深静脉血栓形成或肺栓塞而出现抗凝并发症。经皮置入在血管造影室采用局部麻醉完成，所有患者耐受性良好。在短期随访（3个月至1年）期间，仅发生了3例与经皮置入相关的并发症。这些并发症包括2例患者出现腿部深静脉血栓形成，1例患者滤器放置错误。这3例患者对这些并发症耐受性良好。我们得出结论，格林菲尔德腔静脉滤器可通过经皮穿刺轻松置入。我们的经验表明相关发病率极低且无死亡病例。
